5393342026-04-012026-06-305393342026-06-305393342026-04-012026-06-30in-capmkt:OtherExpenses1Member5393342026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15393342026-06-30Statement15393342026-04-012026-06-30Statement15393342026-06-30StatementDynamic1I1Statement1iso4217:INRxbrli:pureiso4217:INRxbrli:shares539334SHREEPUSHKNAINE712K01011Shree Pushkar Chemicals & Fertilisers LimitedMain BoardEquity2026-04-012027-03-312026-08-122026-08-06INRLakhsQuarterlyFirst quarterSingle segmentChemicals and Fertilisers2026-08-1216:00:002026-08-1218:00:00Not applicabletrue1falseNOT APPLICABLE2026-04-012026-06-30UnauditedStandalone157409900041118000161521700011188320000-119705000954150001703200047062000287312000144594800016926900001692690002978100018293000480740000121195000000012119500099000121294000323377000103.753.66003.753.66Other Expenses287312000Re-measurement of net defined benefit obligations99000990000099000Preferential Issues2025-12-27299999870000002026-06-30falsefalsefalseNilNilMr. Pankaj ManjaniCompany Secretary and Compliance OfficerMumbai2026-08-12For undertaking investment in Madhya Bharat Phosphate Private Limited*, a Material Wholly Owned Subsidiary of the Company, in the form of Equity/Quasi Equity, Debt/Loan instruments, Inter-Corporate Loan/Deposit which will be utilized by such Subsidiary as a Capital Expenditure for Complex Fertilisers and further Expansion of Unit at Meghnagar, Jhabua, Madhya Pradesh. (“Investment in Subsidiary”) *As the Petition of Scheme of Amalgamation of Madhya Bharat Phosphate Private Limited and Kisan Phosphates Private Limited, another Material Wholly Owned Subsidiary of Shree Pushkar Chemicals & Fertilisers Limited is pending before Hon'ble National Company Law Tribunal, Mumbai Bench, this Object shall deemed to include Kisan Phosphates Private Limited if Amalgamation is approved by Hon'ble National Company Law Tribunal, Mumbai Bench before utilizing the proceeds of this Object. None29999987000000074999968000000*It is the total issue size. However, as on 30th June, 2026, the Company has received Rs. 7,49,99,968 as stipulated amount of 25% of the Issue Size as subscription amount in accordance with the provisions of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. <br /> <br /> Balance 75% of the Issue Size will be received as and when the conversion option is exercised by the Warrant Holder to convert Full Convertible Warrants into fully paid up Equity Share of face value of Rs. 10/- each of the Company during the tenure of 18 months of the Warrant. <br /> <br /> Deviation and variation could mean: <br /> <br /> (a) Deviation in the objects or purposes for which the funds have been raised or <br /> (b) Deviation in the amount of funds actually utilized as against what was originally disclosed or <br /> (c) Change in terms of a contract referred to in fund raising document i.e prospectus, letter of offer, etc. <br /> <br />